Real-Time Monitoring of Patient Centered Outcomes in English And Non-English-Speaking Patients

J
Jordan Holmes

Primary Investigator

Overview

An unmet need remains to provide culturally and linguistically competent healthcare both at the legislative and implementation levels. Our hypothesis is that capturing PROs in patients’ native language would overcome the barriers inherent to physician-patient language discordance 

Description

1. To determine if real time monitoring of PROs during radiation treatment for pelvic cancers (prostate and gynecological) reduces bowel symptom severity as measured by EPIC-26.

2. To determine if real time monitoring of PROs during radiation treatment for pelvic cancers (prostate and gynecological) reduces urinary symptom severity as measured by EPIC-26

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    cancer, radiation therapy,
  • Age: Between 18 Years - 100 Years
  • Gender: All

Inclusion Criteria:
  • 1.     Age≥ 18 at time of consent.
    2.     Ability to provide written informed consent and HIPAA authorization.
    3.     Patients must be English or Spanish speaking
    4.     Pathologically proven diagnosis of endometrial, cervical, or prostate cancer.
    5.     Planning to receive definitive or adjuvant radiation therapy (≥ 20 fractions of EBRT) (+/- chemotherapy or hormonal therapy) with curative intent as part of standard of care.
Exclusion Criteria:
  • 1.     Patients taking part in other clinical trials involving the completion of extensive patient reported outcome or quality of life measures
    2.     Patients exhibiting overt psychopathology/cognitive dysfunction in the opinion of the treating investigator and/or principal investigator.
    3.     Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years.
    4.     Prior radiation to the pelvis
    5.     Prior treatment with platinum-based chemotherapy that is outside of the current treatment window
    6.     Prior exposure to hormonal treatment that is outside of the current treatment window

Updated on 30 Apr 2024. Study ID: 13393, CTO-IUSCCC-0765
Please visit our main page to search for other studies you may be interested in. If you need help finding a study or have any questions, please contact us at inhealth@iu.edu

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center